Detalles de la búsqueda
1.
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit.
Cancer Immunol Immunother
; 71(6): 1531-1543, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34661709
2.
A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission.
Cytotherapy
; 14(7): 851-9, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22799277
3.
KHYG-1 and NK-92 represent different subtypes of LFA-1-mediated NK cell adhesiveness.
Front Biosci (Elite Ed)
; 3(1): 166-78, 2011 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21196295
4.
Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignancies.
Exp Hematol
; 39(9): 904-14, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21703984
5.
Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy.
Exp Hematol
; 39(9): 897-903.e1, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21703986
Resultados
1 -
5
de 5
1
Próxima >
>>